Carl Zeiss Meditec AG

Carl Zeiss Meditec AG, which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Carl Zeiss Meditec Group’s long-term goal is to leave a lasting mark in the fields of ophthalmology and microsurgery.

With our ambition to break new ground, our global teams have succeeded in developing innovative technologies, digital solutions and specific applications for the workflows of our customers, which enable them to preserve vision into old age and fight brain tumors. In addition to developing cutting-edge medical products, we focus on developing and establishing solutions that enable the secure and efficient management of health data, improve workflow automation, and enable the use of intelligent algorithms such as machine learning or artificial intelligence. Our workflow solutions, designed for a wide variety of clinical workflows, enable us as a medical technology company to take a holistic approach to addressing customer needs and to make a significant contribution to the digital transformation of the healthcare system.

For the ophthalmology market, we offer one of the most comprehensive product portfolios in the world. It includes systems as well as consumables for retinal, cataract and corneal refractive surgery, and offers products and solutions for the diagnosis, treatment and management of chronic eye diseases.

Our mission is to set new standards with our cutting-edge medical products and integrated workflow solutions. We drive progress, efficiency and access to healthcare technology, supporting doctors to improve their patients' quality of life.